Product Information
LEVSIN-SL 0.125 MG TABLET SL is a brand product labeled by Viatris Specialty LLC, priced at $2.7044 per EA under NDC 68220011310. Its NADAC has been published 94 times since Sep 18, 2024.
The High Outlier badge above means this manufacturer's average price in the hyoscyamine sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.125 mg/1
Manufacturer
Viatris Specialty LLCNDC
68220011310
Classification
Brand
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYOSCYAMINE SULFATEApproval Type
Unapproved
On Market Since
12/1/2008
Price Statistics
The NADAC for LEVSIN-SL 0.125 MG TABLET SL has been published 94 times since Sep 18, 2024, and over the history we have for it it has risen 5.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7044 per EA |
|---|---|
| All-time high | $2.7142 (Jul 15, 2026) |
| All-time low | $2.5253 (Oct 23, 2024) |
| 52-week high | $2.7142 |
| 52-week low | $2.6515 |
| Median price | $2.6515 |
| Average price | $2.6451 |
| Largest weekly change | +5.0% (Jan 15, 2025) |
| Weeks tracked | 94 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viatris Specialty LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
hyoscyamine sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVSIN-SL 0.125 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for LEVSIN-SL 0.125 MG TABLET SL, manufactured by Viatris Specialty LLC, is $2.7044 per EA (NDC 68220011310), effective Sep 30, 2026.
How has the price of LEVSIN-SL 0.125 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for LEVSIN-SL 0.125 MG TABLET SL has risen 5.6%. It has been tracked across 94 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for LEVSIN-SL 0.125 MG TABLET SL?
Since Sep 18, 2024, the NADAC for LEVSIN-SL 0.125 MG TABLET SL has ranged from a low of $2.5253 (Oct 23, 2024) to a high of $2.7142 (Jul 15, 2026), with a median of $2.6515 per EA.
Are there cheaper alternatives to LEVSIN-SL 0.125 MG TABLET SL?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYOSCYAMINE 0.125 MG ODT, is $0.1442 per EA — about 95% below LEVSIN-SL 0.125 MG TABLET SL.
Who manufactures LEVSIN-SL 0.125 MG TABLET SL?
LEVSIN-SL 0.125 MG TABLET SL (NDC 68220011310) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.